Year |
Citation |
Score |
2020 |
Gordesli-Duatepe FP, Park BJ, Kawas LH, Abu-Lail NI. Atomic Force Microscopy Investigation of the Contributions of Cell-Wall Biomacromolecules to Their Adherence and Mechanics. The Journal of Physical Chemistry. B. PMID 32544332 DOI: 10.1021/acs.jpcb.0c04025 |
0.44 |
|
2019 |
Vanderwerff BR, Church KJ, Kawas LH, Harding JW. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma. Cytokine. 123: 154762. PMID 31254927 DOI: 10.1016/j.cyto.2019.154762 |
0.92 |
|
2015 |
Uribe PM, Kawas LH, Harding JW, Coffin AB. Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure. Frontiers in Cellular Neuroscience. 9: 3. PMID 25674052 DOI: 10.3389/fncel.2015.00003 |
0.92 |
|
2015 |
Wright JW, Kawas LH, Harding JW. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology. 125: 26-46. PMID 25455861 DOI: 10.1016/j.pneurobio.2014.11.004 |
0.8 |
|
2014 |
Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, Harding JW. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. The Journal of Pharmacology and Experimental Therapeutics. 351: 390-402. PMID 25187433 DOI: 10.1124/jpet.114.218735 |
0.8 |
|
2013 |
Wright JW, Kawas LH, Harding JW. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases. Frontiers in Endocrinology. 4: 158. PMID 24298267 DOI: 10.3389/fendo.2013.00158 |
0.92 |
|
2013 |
McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of Pharmacology and Experimental Therapeutics. 344: 141-54. PMID 23055539 DOI: 10.1124/jpet.112.199497 |
0.8 |
|
2013 |
Kawas LH, Benoist CC, Harding JW, Wayman GA, Abu-Lail NI. Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy. Nanomedicine : Nanotechnology, Biology, and Medicine. 9: 428-38. PMID 22960190 DOI: 10.1016/j.nano.2012.08.008 |
0.8 |
|
2012 |
Wright JW, Wilson WL, Wakeling V, Boydstun AS, Jensen A, Kawas L, Harding JW. The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats. Brain Sciences. 2: 298-318. PMID 24961196 DOI: 10.3390/brainsci2030298 |
0.92 |
|
2012 |
Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW. Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48. PMID 22129598 DOI: 10.1124/jpet.111.188136 |
0.8 |
|
2011 |
Kawas LH, Yamamoto BJ, Wright JW, Harding JW. Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity. The Journal of Pharmacology and Experimental Therapeutics. 339: 509-18. PMID 21859930 DOI: 10.1124/jpet.111.185694 |
0.8 |
|
Show low-probability matches. |